James Mackey
MD
Clinical Oncologist
My goal is to obtain the best possible outcome for each and every patient and help them get through the most difficult challenge of their life.
Languages spoken
English
Expert in
Medical Oncology, Hematology, Palliative Medicine, Internal Medicine and Obesity Medicine
Overview
Centers
Specializes in
Treatments
James Mackey, MD is a native of Dallas, Texas with over 16 years of oncology and hematology experience. He also has experience working with holistic approaches for managing side effects from treatment.
Dr. Mackey received his bachelors in biology from the University of Texas Austin and received his medical degree from the University of Texas San Antonio. He then completed his fellowship training in medical oncology at Baylor University Medical Center in Dallas, TX. He is board-certified in medical oncology, internal medicine, hospice and palliative medicine, and obesity medicine.
Dr. Mackey believes that cancer patients deserve individualized treatments and should be presented with treatment options. He believes that his willingness to listen and explain helps his patient feel as though they are an integral piece of their healthcare team.
.svg){kind=icon}
Career positions
Current position(s)
- GenesisCare, Medical Oncology Division – Medical Oncologist, Rogers, AR
Past position(s)
- Alara Medical Group, Concierge medical oncology – Medical Oncologist
- Genesis Medical Group, Medical Oncology Division – Medical Oncologist, Houston, TX
- Choice Cancer Care, Medical Oncology Division - Director of Medical Oncology, Southlake, TX
- Dallas Oncology Consultants, Medical Oncology Division – Principal Investigator, Dallas, TX
Education
Universities
- University of Texas Austin, Bachelor of Arts in Biology
- University of Texas San Antonio, Doctorate of Medicine
Residencies
- Presbyterian Hospital of Dallas, Internal Medicine, Dallas, TX
Internships
- Presbyterian Hospital of Dallas, Internal Medicine, Dallas, TX
Fellowships
- Baylor University Medical Center, Medical Oncology, Dallas, TX
Accomplishments
Publications
- Miles B, Mackey JD. Increased Risk of Second Primary Malignancy and Mortality at ten Years After Stem Cell Transplant for Multiple Myeloma: An analysis of 14,532 patients. Cureus. 2021;13(7). doi:10.7759/cureus.16372
- Miles B, Mackey JD. The Lung Cancer Obesity Paradox: An analysis of 432,924 patients. JCO. 2021;39(15_suppl):10578-10578. doi:10.1200/JCO.2021.39.15 suppl.10578
- Miles B, Moth J, Mackey JD. Usefulness of Nivolumab plus Ipilimumab Immunotherapy for Metastatic Uveal Melanoma. Proc (Bayl Univ Med Cent). 2020;34(1):118-119. Published 2020 Oct 19. doi:10.1080/08998280.2020.1825587
- Miles B, Mackey JD. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Lung Cancer: History, Epidemiology, and Market Outlook. Cureus. 2021;13(2). doi:10.7759/cureus.13470
- Miles B, Panchbhavi M, Mackey JD. Analysis of Fracture Incidence in 135 Patients With Pregnancy and Lactation Osteoporosis (PLO). Cureus. 2021;13(10). doi:10.7759/cureus.19011
- Miles B, Martinez N, Atieh K, Mackey JD. Atypical Chronic Myeloid Leukemia: Case Report and Review of Literature. Eurasian Journal of Medicine and Oncology. 2021;5(4):358-360. doi:10.14744/ejmo.2021.24484
- Miles B, Mackey JD. Resensitization to ESA therapy After Use of a Hypomethylating Agent in Myelodysplastic Snydrome. European School of Hematology, 11/13-15/2020